Navigation Links
Extensive research demonstrates fructose does not increase food intake or impact weight
Date:2/10/2011

A new comprehensive review, recently published in Critical Reviews in Food Science and Nutrition, concludes that fructose does not increase food intake or impact body weight or blood triglycerides in overweight or obese individuals.

The review examined data regarding the normal consumption of fructose and any subsequent development of alterations in lipid or and/or glucose metabolism or weight gain in overweight people. Researchers were unable to find any relationship between fructose and hyperlipidemia or increased weight. These findings support the results of a similar review that analyzed the role of fructose on blood lipids, glucose, insulin and obesity among the healthy, normal weight population.

Dr. Laurie Dolan, lead author of both studies concluded that "there is no evidence that ingestion of normal amounts of fructose is associated with an increase in food intake or body weight (compared to other carbohydrates), when it is not consumed in caloric excess. This is true for both normal weight people and people that are overweight or obese."

Fructose is a natural simple sugar found in fruits, vegetables and their juices, as well as honey. In its pure form, fructose has been used as a sweetener since the mid-1850s and has advantages for certain groups, including people with diabetes and those trying to control their weight. Fructose in crystalline form has been widely used for the past 20 years as a nutritive sweetener in foods and beverages.

Although many consumers have confused crystalline fructose with high fructose syrups [also known as high fructose corn syrup (HFCS) and isoglucose], they are not the same. Like sucrose, high fructose syrups contain nearly equal amounts of glucose and fructose. This change in composition is chemically significant and leads to differences in food applications and specific physiological responses.

Both of the recent fructose reviews utilized an evidence-based app
'/>"/>

Contact: Beth Hubrich
bhubrich@kellencompany.com
404-252-3663
Kellen Communications
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. 5 standout species for extensive green roofs
2. Jumping genes provide extensive raw material for evolution, Penn study finds
3. Canadian excellence strengthened by extensive adoption of open access
4. Most extensive genetic resource for reef-building coral created
5. SLU research implicates natural toxin as triggering Parkinsons disease
6. New research helps explain how progesterone prevents preterm birth
7. New research helps explain how progesterone preventspreterm birth
8. Single-cell marine predators unique survival mechanisms revealed: UBC research
9. Research helps drivers cut fuel use
10. Boston University School of Medicine researchers receive NIMH brain awards
11. Research team honored for innovative science to advance cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
(Date:5/8/2015)... SAN JOSE, Calif. , May 8, 2015 ... human interface solutions, today announced that members of the executive ... J.P. Morgan 43rd Annual Technology, Media and Telecom Conference ... Westin Waterfront Hotel in Boston, MA ... Date: May 27, 2015 Time: 2:45pm ET Location: The New ...
(Date:4/27/2015)... , April 27, 2015  For more than four ... show has been the premier worldwide event for the ... is a must-attend event for any local, national, or ... the emerging commercial markets and current applications of unmanned ... of this projected $48 billion industry, and how it ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Synaptics to Present at Upcoming Investor Conferences 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... 26, 2012   Reportlinker.com announces that a ... its catalogue: Biometrics Market ... TechNavio,s analysts forecast the ... a CAGR of 42.4 percent over the ...
... University of Massachusetts Amherst resource economist Sylvia Brandt, with colleagues ... upward for childhood asthma and for the first time include ... study released this week in the early online version of ... of asthma due to pollution is much higher than past ...
... The Department of Energy,s Pacific Northwest National Laboratory ... that improves research sample analysis to the marketplace. ... PNNL is receiving a 2012 award for Excellence ... network that encourages federal laboratories to transfer lab-developed ...
Cached Biology News:Biometrics Market in India 2010 - 2014 2Asthma rate and costs from traffic-related air pollution are much higher than once believed 2PNNL recognized for technology transfer 2
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... King of Prussia, PA (PRWEB) May 21, 2015 ... that Julia O’Neill has joined the firm as senior ... more than 30 years of experience in the management ... the vaccines, biologics, pharmaceutical and chemical industries. , “We’re ... enhance our longstanding capabilities in data analytics,” said Dr. ...
(Date:5/20/2015)...  Select Medical Corporation ("Select") (NYSE: SEM ... early termination of the waiting period under the ... amended, applicable to the acquisition of Concentra Inc. ... that Select has created with Welsh, Carson, Anderson & ... MJ Acquisition Corporation has signed a definitive purchase ...
(Date:5/20/2015)... May 20, 2015  Haemonetics Corporation (NYSE: HAE ... & CEO, will present at The Jefferies 2015 Global ... on June 1 st , 2015 at 8:30am Eastern ... Concannon,s presentation live via webcast at: http://wsw.com/webcast/jeff88/hae ... HAE ) is a global healthcare company dedicated ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... to Record Highs, BEDFORD, Mass., Jan. 31 ... company specializing in,diagnostics, imaging systems and interventional devices dedicated ... results for the,quarter ended December 29, 2007., ... of $371.4 million. -- Merger with Cytyc Corporation ...
... - Conference call webcast Thursday, January 31, 2008, 8:30 a.m. EST ... ... Jan. 31 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today ... an Isis subsidiary.,The investment will allow Ibis to further develop the ...
... Strengthened Balance Sheet and Advancing Products in 2008 - ... a.m. Eastern Time -, BRANFORD, Conn., Jan. 31 ... results for the,fourth quarter and fiscal year ended December 31, ... fourth quarter of 2007,of $11.0 million, or $0.20 per share, ...
Cached Biology Technology:Hologic Announces First Quarter Fiscal 2008 Operating Results 2Hologic Announces First Quarter Fiscal 2008 Operating Results 3Hologic Announces First Quarter Fiscal 2008 Operating Results 4Hologic Announces First Quarter Fiscal 2008 Operating Results 5Hologic Announces First Quarter Fiscal 2008 Operating Results 6Hologic Announces First Quarter Fiscal 2008 Operating Results 7Hologic Announces First Quarter Fiscal 2008 Operating Results 8Hologic Announces First Quarter Fiscal 2008 Operating Results 9Hologic Announces First Quarter Fiscal 2008 Operating Results 10Hologic Announces First Quarter Fiscal 2008 Operating Results 11Hologic Announces First Quarter Fiscal 2008 Operating Results 12Hologic Announces First Quarter Fiscal 2008 Operating Results 13Hologic Announces First Quarter Fiscal 2008 Operating Results 14Hologic Announces First Quarter Fiscal 2008 Operating Results 15Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 2Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 3Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 4CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 2CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 3CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 4CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 5CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 6CuraGen Reports Fourth Quarter and Year End 2007 Financial Results 7
... Cell Cultures (ECACC) in conjunction with the ... of England, Bristol, UK, have produced standardised ... HER2, oestrogen and progresterone receptor assays. The ... formalin fixed, breast cancer cell lines; MDA-MD-361, ...
... When Ambion introduced the highly potent TURBO ... a new standard was set in DNA removal ... of DNase I that is much more efficient ... trace amounts of unwanted DNA. TURBO DNase binds ...
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
PP2B-Abeta (C-20)...
Biology Products: